Per FY2026 ICD-10-CM Official Guidelines, the 6th character for complications is required when documented
Common Side Effects When side effects occurred, they were typically mild, transient, and similar in frequency to placebo groups: Reported Adverse Effects Most Common (occurring in small percentage of participants): Mild to moderate headaches (most frequently reported, often resolving with continued use) Injection site reactions (minor redness, swelling, or irritation at injection site) Gastrointestinal effects (particularly at higher oral doses: mild nausea, diarrhea, flatulence) Fatigue (reported occasionally during initial adaptation period) Rare Events: One case of chest tightness was deemed possibly related to treatment in safety trials
Conclusions: Cere treatment was well tolerated and resulted in significant improvements in the global score two months after the end of active treatment
Consumers are no longer satisfied with outdated multivitamins or general supplementsthey want precision formulas backed by research
Kisspeptin offers a fundamentally different and potentially complementary mechanism targeting the hypothalamic dysfunction at the root of PMOS-related anovulation with early human data supporting its relevance